Letter to the editor : Unexpected high mortality in COVID-19 and diabetic ketoacidosis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:110 |
|---|---|
| Enthalten in: |
Metabolism: clinical and experimental - 110(2020) vom: 10. Sept., Seite 154301 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chamorro-Pareja, Natalia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 31.08.2020 Date Revised 10.01.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.metabol.2020.154301 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311681565 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311681565 | ||
| 003 | DE-627 | ||
| 005 | 20231225142755.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.metabol.2020.154301 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1038.xml |
| 035 | |a (DE-627)NLM311681565 | ||
| 035 | |a (NLM)32589899 | ||
| 035 | |a (PII)S0026-0495(20)30165-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chamorro-Pareja, Natalia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Letter to the editor |b Unexpected high mortality in COVID-19 and diabetic ketoacidosis |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.08.2020 | ||
| 500 | |a Date Revised 10.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 700 | 1 | |a Parthasarathy, Sahana |e verfasserin |4 aut | |
| 700 | 1 | |a Annam, Jayabhargav |e verfasserin |4 aut | |
| 700 | 1 | |a Hoffman, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Coyle, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Kishore, Preeti |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Metabolism: clinical and experimental |d 1952 |g 110(2020) vom: 10. Sept., Seite 154301 |w (DE-627)NLM000020761 |x 1532-8600 |7 nnns |
| 773 | 1 | 8 | |g volume:110 |g year:2020 |g day:10 |g month:09 |g pages:154301 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.metabol.2020.154301 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 110 |j 2020 |b 10 |c 09 |h 154301 | ||